A retrospective case series suggested that faricimab (Vabysmo) intravitreal injections may be associated with rare cases of ...
The effort represents a consortium of researchers from Penn Medicine, Penn Engineering, the University of Michigan Kellogg ...
Early results of a real-world study of faricimab demonstrated sustainable improvements in visual acuity and retinal anatomic ...
Retinal diseases are at the forefront of a quiet revolution in the realm of ophthalmology. Gene therapy, once a distant dream ...
The upcoming M4 MacBook Pro may look a great deal, but Apple has something that will trump this new macOS-powered laptop.
A real-world study of an FDA-approved gene therapy for inherited retinal disease shows younger patients gain more visual ...
The clock is ticking, but don't worry because we've rounded up all the deals you could dream of — and they're actually good.
Learn how Retina won the award for communications agency of the year with its year of resilience and record growth.
The arrival of a new iPhone always stirs excitement and a flurry of questions, chief among them: is it worth the upgrade?
Follow the Company on its website, LinkedIn, or X. The Ocular Therapeutix logo and DEXTENZA ® are registered trademarks of Ocular Therapeutix, Inc. AXPAXLIâ„¢, PAXTRAVAâ„¢, ELUTYXâ„¢, and Ocular ...
Know someone who would love Medik8's bestselling Crystal Retinal wrinkle-fighting treatment and want to save money on it? This Christmas gift is a must for skincare fans ...
Ocular Therapeutix's Elutyx drug delivery platform offers sustained long-term effects. See why OCUL stock is a Buy.